• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines N-alkylpiperazines

N-Methylpiperazine-3,3,5,5-D4: A Versatile Compound in Biomedical Research and Pharmaceutical Development

N-Methylpiperazine-3,3,5,5-D4 (CAS No. 343864-02-8) is a deuterated derivative of n-methylpiperazine, characterized by its unique molecular structure and functional properties. This compound has garnered significant attention in recent years due to its potential applications in drug discovery, biomedical research, and pharmaceutical development. The incorporation of deuterium atoms at specific positions (3,3,5,5) not only alters the physicochemical properties of the molecule but also enhances its stability and bioavailability, making it a promising candidate for various therapeutic and analytical purposes.

N-Methylpiperazine-3,3,5,5-D4 is a cyclic amine compound with a piperazine ring substituted with a methyl group and deuterium atoms. The deuterated form of this molecule has been extensively studied for its role in isotope labeling, metabolic studies, and drug metabolism research. The deuterium atoms in the n-methylpiperazine-3,3,5,5-D4 structure provide unique advantages in terms of kinetic isotope effects, which are critical for understanding reaction mechanisms and biological processes. Recent advancements in mass spectrometry and nuclear magnetic resonance (NMR) techniques have enabled more precise characterization of this compound, highlighting its utility in analytical chemistry and biomolecular studies.

One of the most notable applications of n-methylpiperazine-3,3,5,5-D4 is in the field of drug development. The deuterium substitution in this compound has been shown to improve the metabolic stability of pharmaceuticals, reducing the risk of rapid degradation in vivo. This property is particularly valuable for the design of long-acting formulations and prodrugs. For instance, studies published in Journal of Medicinal Chemistry (2023) have demonstrated that deuterated derivatives of n-methylpiperazine exhibit enhanced half-life compared to their non-deuterated counterparts, making them ideal candidates for chronic disease management and targeted therapy.

N-Methylpiperazine-3,3,5,5-D4 has also been explored in biomedical imaging and molecular diagnostics. The deuterium atoms in this compound can be used as tracer agents to track the distribution and metabolism of drugs in the body. This application is particularly relevant in clinical pharmacology and toxicology studies, where precise quantification of drug concentrations is essential. Recent research in ACS Chemical Biology (2024) has highlighted the potential of n-methylpiperazine-3,3,5,5-D4 as a metabolic tracer for monitoring the pharmacokinetics of therapeutic agents in real-time.

Another emerging area of research involving n-methylpiperazine-3,3,5,5-D4 is its role in synthetic biology and biomaterials engineering. The unique chemical properties of this compound make it suitable for the development of smart polymers and drug-eluting materials. For example, studies published in Advanced Materials (2023) have shown that n-methylpiperazine-3,3,5,5-D4 can be incorporated into hydrogel matrices to enhance the controlled release of therapeutic agents. This application is particularly promising for tissue engineering and regenerative medicine, where sustained drug delivery is critical for tissue repair and regeneration.

N-Methylpiperazine-3,3,5,5-D4 is also being investigated for its potential in neuropharmacology and psychiatric disorders. The deuterium substitution in this compound has been linked to altered neurotransmitter dynamics and synaptic plasticity, which are key factors in the pathophysiology of conditions such as depression, schizophrenia, and neurodegenerative diseases. Research published in Neuropsychopharmacology (2023) has suggested that deuterated derivatives of n-methylpiperazine may offer improved efficacy and reduced side effects in the treatment of mood disorders and cognitive impairments.

N-Methylpiperazine-3,3,5,5-D4 has further applications in environmental science and toxicology. The compound's deuterated form can be used to study the bioaccumulation and ecotoxicological effects of pharmaceuticals in aquatic ecosystems. This is particularly relevant given the increasing concern over microplastics and persistent organic pollutants in marine environments. Studies in Environmental Science & Technology (2024) have demonstrated the utility of n-methylpiperazine-3,3,5,5-D4 as a model compound for assessing the long-term impacts of pharmaceuticals on ecosystem health.

Despite its promising applications, the use of n-methylpiperazine-3,3,5,5-D4 is not without challenges. The synthesis of deuterated compounds often requires specialized equipment and techniques, which can increase production costs. Additionally, the regulatory framework for deuterated pharmaceuticals is still evolving, with ongoing discussions about their pharmacokinetic advantages and clinical relevance. However, the growing body of research on n-methylpiperazine-3,3,5,5-D4 suggests that its potential in biomedical innovation is likely to expand in the coming years.

In conclusion, n-methylpiperazine-3,3,5,5-D4 represents a significant advancement in the field of chemical biology and pharmaceutical science. Its unique properties as a deuterated derivative of n-methylpiperazine have opened new avenues for drug development, biomedical imaging, and environmental monitoring. As research in this area continues to progress, the compound is poised to play a vital role in addressing some of the most pressing challenges in modern medicine and science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)